Skip to content

Opening book details…

About this Medicine article

355TiPPhase III clinical trials of atezolizumab compared with standard chemotherapy in PD-L1–selected chemotherapy-naïve patients with advanced NSCLC: by Herbst, R.S.; de Marinis, F.; Jassem, J.; Spigel, D.R.; Shankar, G.; Mocci, S.; Sandler, A.; Lopez-Chavez, A.; Li, S.; Giaccone, G. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Herbst, R.S.; de Marinis, F.; Jassem, J.; Spigel, D.R.; Shankar, G.; Mocci, S.; Sandler, A.; Lopez-Chavez, A.; Li, S.; Giaccone, G.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2015
Language
EN
Field
Medicine (Health Sciences)

More by Herbst, R.S.; de Marinis, F.; Jassem, J.; Spigel, D.R.; Shankar, G.; Mocci, S.; Sandler, A.; Lopez-Chavez, A.; Li, S.; Giaccone, G.

Browse all works by Herbst, R.S.; de Marinis, F.; Jassem, J.; Spigel, D.R.; Shankar, G.; Mocci, S.; Sandler, A.; Lopez-Chavez, A.; Li, S.; Giaccone, G.